Answer
It is unknown whether rasburicase (Fasturtec) passes into human breast milk; infant exposure is expected to be very low because it is a protein, but breastfeeding benefits should be weighed against potential risks to the infant during treatment.
Sources for this answer
- Fasturtec 1.5 mg/ml powder and solvent for concentrate for solution for infusionSANOFI · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 23Document updated
Sources checked